Skip to content

PharmaBXL

Active
Private limited companyfounded 2022active for 3 yearsZavelput 17, 1000 Brussel, BelgiumKBO/BCE: BE 0795.508.480
Summary

The computed 12-month bankruptcy probability of PharmaBXL is 2.9% (moderate). The 2024 annual accounts show equity of €382,053 and a net result of €241,143, of which €242,565 non-recurring income. Its solvency ranks better than 40% of 9,457 sector peers (NACE 82, financial year 2024). The company has been active since 2022 and the Belgian Official Gazette contains no insolvency or warning signals.

Risk analysisFollow ReportCompare
PharmaBXLActiveChecked score 52/100
Risk analysis ReportCompare

Group and network

Connections & network

10 connected companies
Depth
AMPHIKTION, Shared corporate director AAMPHIKTIONAnastrophi, Shared corporate director AAnastrophiApotheek Van Backlé.Wemmel, Shared corporate director AVApotheek VanBacklé.WemmelAspis Aegis, Shared corporate director AAAspis AegisAUTONOMYCS, Shared corporate director AAUTONOMYCSCANTILIS, Shared corporate director CCANTILISCuraevia, Shared corporate director CCuraeviaLeapStation, Shared corporate director LLeapStationSierra House, Shared corporate director SHSierra HouseZORGPUNT, Shared corporate director ZZORGPUNTPharmaBXL PharmaBXL0795.508.480
Shared directors
This company Company Director Shareholding +N: links not shown yet Click a node to look further, drag to arrange, zoom with the mouse wheel.
Linked via shared directors
AMPHIKTION
Shared corporate director
→
Anastrophi
Shared corporate director
→
Apotheek Van Backlé.Wemmel
Shared corporate director
→
Aspis Aegis
Shared corporate director
→
Show 6 more companies with a shared director
AUTONOMYCS
Shared corporate director
→
CANTILIS
Shared corporate director
→
Curaevia
Shared corporate director
→
LeapStation
Shared corporate director
→
Sierra House
Shared corporate director
→
ZORGPUNT
Shared corporate director
→

We would like to set cookies. That happens only with your consent. What we measure